The news sent UPI shares up 8.2% to $3.30 apiece as of about 9:50 a.m. today.
"We are very pleased that Humana has incorporated the Urgent PC neuromodulation system into their incontinence coverage policy," Uroplasty’s sales & marketing senior vice president Darin Hammers said in prepared remarks. "This decision will now provide more patients access to the benefits of this clinically and cost-effective therapy. Urgent PC delivers office-based, minimally invasive neuromodulation for OAB patients who are affected by this chronic condition."
The Urgent PC device uses percutaneous tibial nerve stimulation to treat overactive bladder with a non-implanted electrode to stimulate the sacral nerve plexus and alleviate OB symptoms including urinary urgency, urinary frequency and urge incontinence.
Humana, the 6th-largest private U.S. health insurer, has nearly 9 million lives under coverage, according to a press release. Its coverage decision for Urgent PC is for up to 12 months of treatment. Reimbursement rates for Urgent PC under Medicare ranged from $103 to $184 in 2011, according to Uroplasty.